The structural heart devices market size has grown strongly in recent years. It will grow from $11.37 billion in 2025 to $12.48 billion in 2026 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to increasing prevalence of structural heart diseases, aging global population, early adoption of valve replacement technologies, expansion of cardiac specialty centers, improvements in interventional cardiology techniques.
The structural heart devices market size is expected to see strong growth in the next few years. It will grow to $17.23 billion in 2030 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to increasing preference for minimally invasive procedures, rising investments in cardiovascular innovation, expansion of pediatric cardiac interventions, growing adoption of AI-assisted diagnostics, increasing demand for durable and long-lasting implants. Major trends in the forecast period include increasing adoption of transcatheter heart valve procedures, rising demand for minimally invasive cardiac implants, growing integration of advanced imaging and navigation systems, expansion of catheter-based delivery technologies, enhanced focus on patient-specific device design.
The increasing prevalence of cardiovascular diseases is expected to drive the growth of the structural heart device market in the coming years. Cardiovascular diseases (CVDs) encompass a range of conditions that affect the heart and blood vessels, such as coronary artery disease, heart attacks, and strokes. The global incidence of cardiovascular diseases, including heart disease and stroke, has been steadily rising, driven by factors such as sedentary lifestyles, poor diet, obesity, smoking, and aging populations. Structural heart devices are used to treat these diseases by repairing or replacing damaged heart valves, correcting structural defects, and enhancing heart function and patient outcomes. For example, in September 2024, the British Heart Foundation, a UK-based cardiovascular research charity, reported that approximately 7.6 million people in the UK are affected by heart and circulatory diseases, with 4 million males and 3.6 million females living with these conditions. These diseases account for about 27% of all deaths in the UK, resulting in over 170,000 deaths annually, or roughly 480 deaths per day, which equates to one death every three minutes. As a result, the growing prevalence of cardiovascular diseases is fueling the expansion of the structural heart device market.
Major companies in the structural heart devices market are focusing on developing advanced solutions, such as next-generation transcatheter heart valves, to enhance durability, minimize complications, and broaden minimally invasive treatment options. Next-generation transcatheter heart valves are replacement valves designed for minimally invasive procedures, incorporating features like anti-calcification tissue and improved sealing to extend durability and reduce risks compared to earlier models. For instance, in September 2025, Edwards Lifesciences Corporation, a US-based medical technology company, launched a next-generation transcatheter heart valve platform in India, providing a durable, minimally invasive treatment for aortic stenosis in patients ineligible for open-heart surgery. This valve features calcification-resistant tissue to prevent calcium buildup and prolong longevity, a taller outer sealing skirt to minimize paravalvular leaks, and dry tissue storage for easier hospital handling. Additionally, the platform supports a “lifetime management” strategy, enabling minimally invasive valve-in-valve procedures for future interventions and ensuring sustained treatment effectiveness.
In October 2024, Johnson & Johnson, a US-based healthcare technology company, acquired V‑Wave Ltd. for an undisclosed amount. Through this acquisition, Johnson & Johnson aims to enhance its MedTech cardiovascular portfolio and accelerate its presence in high-growth heart‑failure treatment markets. V‑Wave Ltd. is an Israel-based medical device company specializing in structural heart devices.
Major companies operating in the structural heart devices market are Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., LivaNova PLC, Meril Life Sciences Pvt. Ltd., CryoLife Inc., Braile Biomédica, Direct Flow Medical Inc., JenaValve Technology Inc., Micro Interventional Devices Inc., CardioKinetix Inc., Xeltis AG, Ancora Heart Inc., JOMDD Inc., Valcare Medical, BioStable Science & Engineering Inc., Comed B.V., Transcatheter Technologies GmbH.
North America was the largest region in the structural heart devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the structural heart devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the structural heart devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the structural heart devices market by increasing costs of imported medical-grade alloys, polymers, precision catheters, and advanced manufacturing equipment used in valves, occluders, and delivery systems. North America and Europe are most affected due to reliance on cross-border sourcing of specialized components, while Asia-Pacific faces pricing pressure on device exports. These tariffs are raising overall procedure costs and impacting hospital procurement decisions. At the same time, they are driving localized manufacturing, regional clinical supply chains, and increased investment in domestic cardiovascular device production.
The structural heart devices market research report is one of a series of new reports that provides structural heart devices market statistics, including structural heart devices industry global market size, regional shares, competitors with a structural heart devices market share, detailed structural heart devices market segments, market trends and opportunities, and any further data you may need to thrive in the structural heart devices industry. This structural heart devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Structural heart devices are specialized medical implants or tools tailored for treating various structural defects or abnormalities affecting the heart. They are utilized to repair or replace damaged heart structures, such as valves or septa, thereby restoring normal heart functions and enhancing patient outcomes.
The primary types of structural heart devices include heart valve devices, annuloplasty rings, occluders, and delivery systems. Heart valve devices are medical tools crafted to repair or replace damaged heart valves, ensuring proper blood flow through the heart. These procedures encompass replacement procedures, repair procedures for indications such as atrial septal defect, patent foramen ovale, ventricular septal defect, aortic valve stenosis, and others, catering to age group categories including pediatrics and adults.
The structural heart devices market consists of sales of paravalvular leak closure devices, endovascular stents, and percutaneous mitral valve replacement. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The structural heart devices market size is expected to see strong growth in the next few years. It will grow to $17.23 billion in 2030 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to increasing preference for minimally invasive procedures, rising investments in cardiovascular innovation, expansion of pediatric cardiac interventions, growing adoption of AI-assisted diagnostics, increasing demand for durable and long-lasting implants. Major trends in the forecast period include increasing adoption of transcatheter heart valve procedures, rising demand for minimally invasive cardiac implants, growing integration of advanced imaging and navigation systems, expansion of catheter-based delivery technologies, enhanced focus on patient-specific device design.
The increasing prevalence of cardiovascular diseases is expected to drive the growth of the structural heart device market in the coming years. Cardiovascular diseases (CVDs) encompass a range of conditions that affect the heart and blood vessels, such as coronary artery disease, heart attacks, and strokes. The global incidence of cardiovascular diseases, including heart disease and stroke, has been steadily rising, driven by factors such as sedentary lifestyles, poor diet, obesity, smoking, and aging populations. Structural heart devices are used to treat these diseases by repairing or replacing damaged heart valves, correcting structural defects, and enhancing heart function and patient outcomes. For example, in September 2024, the British Heart Foundation, a UK-based cardiovascular research charity, reported that approximately 7.6 million people in the UK are affected by heart and circulatory diseases, with 4 million males and 3.6 million females living with these conditions. These diseases account for about 27% of all deaths in the UK, resulting in over 170,000 deaths annually, or roughly 480 deaths per day, which equates to one death every three minutes. As a result, the growing prevalence of cardiovascular diseases is fueling the expansion of the structural heart device market.
Major companies in the structural heart devices market are focusing on developing advanced solutions, such as next-generation transcatheter heart valves, to enhance durability, minimize complications, and broaden minimally invasive treatment options. Next-generation transcatheter heart valves are replacement valves designed for minimally invasive procedures, incorporating features like anti-calcification tissue and improved sealing to extend durability and reduce risks compared to earlier models. For instance, in September 2025, Edwards Lifesciences Corporation, a US-based medical technology company, launched a next-generation transcatheter heart valve platform in India, providing a durable, minimally invasive treatment for aortic stenosis in patients ineligible for open-heart surgery. This valve features calcification-resistant tissue to prevent calcium buildup and prolong longevity, a taller outer sealing skirt to minimize paravalvular leaks, and dry tissue storage for easier hospital handling. Additionally, the platform supports a “lifetime management” strategy, enabling minimally invasive valve-in-valve procedures for future interventions and ensuring sustained treatment effectiveness.
In October 2024, Johnson & Johnson, a US-based healthcare technology company, acquired V‑Wave Ltd. for an undisclosed amount. Through this acquisition, Johnson & Johnson aims to enhance its MedTech cardiovascular portfolio and accelerate its presence in high-growth heart‑failure treatment markets. V‑Wave Ltd. is an Israel-based medical device company specializing in structural heart devices.
Major companies operating in the structural heart devices market are Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., LivaNova PLC, Meril Life Sciences Pvt. Ltd., CryoLife Inc., Braile Biomédica, Direct Flow Medical Inc., JenaValve Technology Inc., Micro Interventional Devices Inc., CardioKinetix Inc., Xeltis AG, Ancora Heart Inc., JOMDD Inc., Valcare Medical, BioStable Science & Engineering Inc., Comed B.V., Transcatheter Technologies GmbH.
North America was the largest region in the structural heart devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the structural heart devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the structural heart devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the structural heart devices market by increasing costs of imported medical-grade alloys, polymers, precision catheters, and advanced manufacturing equipment used in valves, occluders, and delivery systems. North America and Europe are most affected due to reliance on cross-border sourcing of specialized components, while Asia-Pacific faces pricing pressure on device exports. These tariffs are raising overall procedure costs and impacting hospital procurement decisions. At the same time, they are driving localized manufacturing, regional clinical supply chains, and increased investment in domestic cardiovascular device production.
The structural heart devices market research report is one of a series of new reports that provides structural heart devices market statistics, including structural heart devices industry global market size, regional shares, competitors with a structural heart devices market share, detailed structural heart devices market segments, market trends and opportunities, and any further data you may need to thrive in the structural heart devices industry. This structural heart devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Structural heart devices are specialized medical implants or tools tailored for treating various structural defects or abnormalities affecting the heart. They are utilized to repair or replace damaged heart structures, such as valves or septa, thereby restoring normal heart functions and enhancing patient outcomes.
The primary types of structural heart devices include heart valve devices, annuloplasty rings, occluders, and delivery systems. Heart valve devices are medical tools crafted to repair or replace damaged heart valves, ensuring proper blood flow through the heart. These procedures encompass replacement procedures, repair procedures for indications such as atrial septal defect, patent foramen ovale, ventricular septal defect, aortic valve stenosis, and others, catering to age group categories including pediatrics and adults.
The structural heart devices market consists of sales of paravalvular leak closure devices, endovascular stents, and percutaneous mitral valve replacement. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Structural Heart Devices Market Characteristics
3. Structural Heart Devices Market Supply Chain Analysis
4. Global Structural Heart Devices Market Trends and Strategies
5. Structural Heart Devices Market Analysis of End Use Industries
7. Global Structural Heart Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Structural Heart Devices Total Addressable Market (TAM) Analysis for the Market
9. Structural Heart Devices Market Segmentation
10. Structural Heart Devices Market Regional and Country Analysis
11. Asia-Pacific Structural Heart Devices Market
12. China Structural Heart Devices Market
13. India Structural Heart Devices Market
14. Japan Structural Heart Devices Market
15. Australia Structural Heart Devices Market
16. Indonesia Structural Heart Devices Market
17. South Korea Structural Heart Devices Market
18. Taiwan Structural Heart Devices Market
19. South East Asia Structural Heart Devices Market
20. Western Europe Structural Heart Devices Market
21. UK Structural Heart Devices Market
22. Germany Structural Heart Devices Market
23. France Structural Heart Devices Market
24. Italy Structural Heart Devices Market
25. Spain Structural Heart Devices Market
26. Eastern Europe Structural Heart Devices Market
27. Russia Structural Heart Devices Market
28. North America Structural Heart Devices Market
29. USA Structural Heart Devices Market
30. Canada Structural Heart Devices Market
31. South America Structural Heart Devices Market
32. Brazil Structural Heart Devices Market
33. Middle East Structural Heart Devices Market
34. Africa Structural Heart Devices Market
36. Structural Heart Devices Market Competitive Landscape and Company Profiles
37. Structural Heart Devices Market Other Major and Innovative Companies
40. Structural Heart Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Structural Heart Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses structural heart devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for structural heart devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The structural heart devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Heart Valve Devices; Annuloplasty Rings; Occluders; Delivery Systems2) By Procedure: Replacement Procedures; Repair Procedures
3) By Indication: Atrial Septal Defect; Patent Foramen Ovale; Ventricular Septal Defect; Aortic Valve Stenosis; Other Indications
4) By Age Group: Pediatric; Adults
Subsegments:
1) By Heart Valve Devices: Transcatheter Heart Valves; Surgical Heart Valves; Annuloplasty Rings2) By Annuloplasty Rings: Mitral Annuloplasty Rings; Aortic Annuloplasty Rings
3) By Occluders: Atrial Septal Defect (Asd) Occluders; Patent Foramen Ovale (Pfo) Occluders
4) By Delivery Systems: Balloon Delivery Systems; Catheter-Based Delivery Systems
Companies Mentioned: Abbott Laboratories; Medtronic Plc; Boston Scientific Corporation; Terumo Corporation; Edwards Lifesciences Corporation; W. L. Gore & Associates Inc.; LivaNova PLC; Meril Life Sciences Pvt. Ltd.; CryoLife Inc.; Braile Biomédica; Direct Flow Medical Inc.; JenaValve Technology Inc.; Micro Interventional Devices Inc.; CardioKinetix Inc.; Xeltis AG; Ancora Heart Inc.; JOMDD Inc.; Valcare Medical; BioStable Science & Engineering Inc.; Comed B.V.; Transcatheter Technologies GmbH
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Structural Heart Devices market report include:- Abbott Laboratories
- Medtronic Plc
- Boston Scientific Corporation
- Terumo Corporation
- Edwards Lifesciences Corporation
- W. L. Gore & Associates Inc.
- LivaNova PLC
- Meril Life Sciences Pvt. Ltd.
- CryoLife Inc.
- Braile Biomédica
- Direct Flow Medical Inc.
- JenaValve Technology Inc.
- Micro Interventional Devices Inc.
- CardioKinetix Inc.
- Xeltis AG
- Ancora Heart Inc.
- JOMDD Inc.
- Valcare Medical
- BioStable Science & Engineering Inc.
- Comed B.V.
- Transcatheter Technologies GmbH
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 12.48 Billion |
| Forecasted Market Value ( USD | $ 17.23 Billion |
| Compound Annual Growth Rate | 8.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
